Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …

Post-acute sequelae of SARS-CoV-2 (PASC), or long COVID syndrome, is emerging as a
major health issue in patients with previous SARS-CoV-2 infection. Symptoms commonly …

Abstracts The coronavirus disease 2019 (COVID-19) affects infected patients even after the
acute phase and impairs their health and quality of life by causing a wide variety of …

The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded
620 million worldwide, still having a profound impact on people's health and daily lives since …

Background COVID‐19 is generating clinical challenges, lifestyle changes, economic
consequences. The pandemic imposes to familiarize with concepts as prevention …

Coronavirus disease 2019 (COVID-19) primarily affects the lungs but the clinical
manifestations vary markedly among the patients involved. In more severe cases, COVID-19 …

Abstract Coronavirus disease 2019 (COVID‐19) is a novel pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …

Background: Recent surveillance studies following nationwide mass vaccination are
investigating rare complications such as myocarditis, pericarditis, and thromboembolic …

Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

Biodegradable magnesium (Mg) alloys are expected to be promising materials for
cardiovascular stents (CVS), which can avoid the long-term clinical problems of current CVS …